TGen’s Mindcrowd Featured on STEM Journals on Sunday, September 21st
TGen’s online cognitive study MindCrowd will be featured on an upcoming episode of STEM Journals on Sunday, September 21st at 7pm on Cox 7 or 1007. MindCrowd is the first research project of its kind. Researchers hope that a million people worldwide will spend...
Read moreGenentech Neuroscientist to Speak at ASU About Advances in Alzheimer’s Drug Development
New discoveries that may increase the effectiveness of Alzheimer’s treatments will be the topic at a Discovery Series presentation at the Biodesign Institute at ASU on Wednesday, Sept. 10 at 10 a.m. Genentech neuroscientist Ryan Watts, PhD, will discuss...
Read moreNew Funding Opportunity Alert — Department of Defense
The Department of Defense Peer Reviewed Alzheimer Research Program has new information available about research funding opportunities and its program goals for the future. This unique research program provides funding to address the long-term consequences of traumatic brain injury as they pertain to...
Read moreGift to University of Arizona’s McKnight Brain Institute Launches Matching Campaign
The University of Arizona has received a $5 million gift for its McKnight Brain Institute that challenges other philanthropists to match the amount to help support ongoing funding for neuroscience research. Click here to read the full article. ....
Read moreNIH Renews Funding of Banner Alzheimer’s Institute and Mayo Clinic Decades-Long Longitudinal Study of Earliest Alzheimer’s Disease Changes
Brain imaging study examines three levels of risk for Alzheimer’s disease Phoenix (August 6, 2014) – The National Institutes of Health (NIH) renewed funding for the Banner Alzheimer’s Institute (BAI) and Mayo Clinic, Phoenix, longitudinal study of the earliest...
Read moreBanner Alzheimer’s Institute Announces Partnership with Novartis in New Study of Alzheimer’s Prevention Treatments
Two drugs to be studied in North America and Europe in volunteers at high risk for disease Copenhagen, Denmark (July 15, 2014) —Researchers from the Banner Alzheimer’s Institute (BAI) today announced a partnership with Novartis in a pioneering medical...
Read moreTwo New Alzheimer’s Drugs Studied In Phoenix
7/15/14 A Phoenix-area research group (Banner Alzheimer’s Institute and its research partners) will team with Swiss pharmaceutical company Novartis to test two experimental drugs that aim to fend off Alzheimer’s disease in older adults who are at high risk...
Read moreDr. Carol Barnes Recognized By The American Psychological Association
Dr. Carol Barnes has been recognized by the American Psychological Association as a 2014 Distinguished Scientific Contribution award recipient. The award recognizes senior scientists for distinguished theoretical or empirical contributions to basic research in psychology. Dr. Barnes will be presented...
Read moreTGen’s MindCrowd Aims To Study One Million Memories
Tgen’s MindCrowd, an online cognitive study, is hoping a million people worldwide will spend 10 minutes taking their online test. With the knowledge they glean from the results, they plan to better understand age’s effect on memory and use...
Read moreHow One Family May Raise Hope For All Alzheimer’s Patients
Dr. Eric Reiman and Dr. Adam Fleisher of Banner Alzheimer’s Institute speak with CBS Sunday Morning about their research work and the hope that one family in Colombia is giving to Alzheimer’s patients all over the world. Click here to view...
Read more